Kaloba (Pelargonium Sidoides Root Liquid Extract, Dried)

Pelargonium sidoides is believed to act through several mechanisms, including stimulation of immune cells, modulation of cytokine release, direct antimicrobial activity against common respiratory pathogens, and enhancement of mucociliary clearance, which together may help reduce symptom severity and duration.

The appropriate dose of Kaloba is determined by a qualified healthcare professional based on the individual’s age, condition, and overall health. Prescribers set the exact amount and frequency, and patients should follow the instructions provided on the label or by their clinician.

Safety data for Pelargonium sidoides during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Kaloba to weigh potential benefits against unknown risks.

To order Kaloba, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Kaloba’s primary active ingredient, Pelargonium sidoides, is distinct from many other OTC cough remedies that rely on decongestants or synthetic expectorants. Clinical observations suggest comparable symptom relief for mild infections, while Kaloba offers a plant‑based option with a different safety and interaction profile.

Kaloba should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from direct sunlight, and avoid exposure to moisture. Do not freeze the product; retain it in its original packaging until use.

Kaloba is supplied as a liquid extract for oral use. The recommended administration method is to measure the prescribed amount using the provided dropper or measuring device and swallow it directly or mix it with a small amount of water or juice, as advised by a healthcare professional.

The most serious risks include rare but severe allergic reactions such as anaphylaxis, serious skin conditions like Stevens‑Johnson syndrome, and potential liver enzyme elevations. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, widespread rash, or jaundice.

Kaloba should be avoided by individuals with known hypersensitivity to Pelargonium sidoides or any other component of the formulation, children under two years of age without medical guidance, pregnant or breastfeeding women unless advised by a physician, and patients taking medications that may interact significantly, such as anticoagulants or immunosuppressants.